RJ-8201

N/A

Report date: 2022/12/30 17:20:40
NMEFirst In Class

Base Information

Drug NameRJ-8201
Drug Alias NameRJ-8201RJ8201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Sgk1 inhibitors
TargetsSerine/threonine-protein kinase Sgk1
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Ruijie Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Ruijie Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A